News ArticleFortis Healthcare Reports Rs 12,991 Lakh Net Profit for Q2 Ending September 30, 2026
Company records Rs 17,769 lakh net profit for six months ending September 30, 2026, with total income of Rs 61,091 lakh in the quarter; results approved by Board and reviewed by auditors
Fortis Healthcare Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026. The company posted a net profit of Rs 12,991 lakh for Q2 and Rs 17,769 lakh for H1 FY 2026-27, with total income rising to Rs 61,091 lakh in Q2. The results include an exceptional gain and are subject to a limited review report by the statutory auditor.
Fortis Healthcare Limited
General / Other
Fortis Healthcare Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit of Rs 12,991 lakh for the quarter and Rs 17,769 lakh for the half year. Total income for the quarter stood at Rs 61,091 lakh, including an exceptional gain of Rs 706 lakh.
The company’s revenue from operations for the quarter was Rs 51,941 lakh, contributing to a total income of Rs 61,091 lakh which includes other income of Rs 9,150 lakh.
Total expenses for the quarter amounted to Rs 47,206 lakh comprising costs such as medical consumables, employee benefits, finance costs, and professional fees to doctors.
The net profit before tax for the quarter was Rs 14,591 lakh, after considering an exceptional gain of Rs 706 lakh.
For the six-month period ended September 30, 2026, the company generated total income of Rs 111,928 lakh and net profit of Rs 17,769 lakh, with total expenses of Rs 93,442 lakh.
The Board of Directors approved these results on November 5, 2026, with the limited review conducted by BSR & Co. LLP, which noted no material modifications in the interim financials but highlighted ongoing regulatory investigations related to prior years.
Highlights
- Net profit of Rs 12,991 lakh in Q2 FY 2026-27
- Six-month net profit at Rs 17,769 lakh
- Quarterly total income at Rs 61,091 lakh
- Exceptional gain included in net profit amounting to Rs 706 lakh in Q2
- Expenses totaled Rs 47,206 lakh for the quarter
- Board meeting held November 5, 2026, approved results and auditor’s limited review report
Key Data Snapshot
What happened
- Fortis Healthcare Limited announced its unaudited standalone financial results for Q2 and H1 FY 2026-27.
- The Board approved the results on November 5, 2026.
- The results include an exceptional gain of Rs 706 lakh for the quarter.
Financial performance
- For the quarter ended September 30, 2026, total income reached Rs 61,091 lakh including Rs 51,941 lakh from operations.
- Total expenses were Rs 47,206 lakh, covering purchases of medical consumables, employee benefits, finance costs, and professional fees.
- Net profit for the quarter was Rs 12,991 lakh, and for six months was Rs 17,769 lakh.
- Exceptional items impacted profit positively by Rs 706 lakh during the quarter.
Regulatory and governance context
- Limited review was performed by BSR & Co. LLP, who did not identify material misstatements.
- The company is cooperating with ongoing investigations by Serious Fraud Investigation Office related to past management and transactions prior to 2018.
- A forensic audit has been ordered by the Delhi High Court regarding certain transactions, with the investigation ongoing.
Highlights
- Net profit of Rs 12,991 lakh in Q2 FY 2026-27
- Six-month net profit at Rs 17,769 lakh
- Quarterly total income at Rs 61,091 lakh
- Exceptional gain included in net profit amounting to Rs 706 lakh in Q2
- Expenses totaled Rs 47,206 lakh for the quarter
- Board meeting held November 5, 2026, approved results and auditor’s limited review report
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 (Ind AS 34)
- Companies Act, 2013
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Sansera Engineering Achieves Record INR 10,915 Million Quarterly Revenue and 59% Normalised PAT Growth in Q2 FY27
Sansera Engineering Limited reported its highest-ever quarterly revenue of INR 10,915 million for Q2 FY27, a 32% increase year-over-year, alongside a normalized profit after tax of INR 1,000 million, up 59% YoY excluding an exceptional litigation-related cost.
Read Full Story
Godfrey Phillips India Declares ₹10 Interim Dividend and Posts ₹16,298 Lakh Profit for Q2 FY2027
Godfrey Phillips India Limited declared an interim dividend of 500% or ₹10 per equity share for the financial year ending March 31, 2027, while reporting an unaudited standalone net profit of ₹16,298 lakh for the quarter ended September 30, 2026.
Read Full Story
IKS Health Doubles Revenue with 103.9% YoY Growth and Boosts EBITDA by 62.5% in Q2 FY27 Post TruBridge Deal
Inventurus Knowledge Solutions Limited (IKS Health) announced strong Q2 FY27 financial results with revenue surpassing INR 15,900 million, marking a 103.9% year-on-year increase supported by its TruBridge acquisition and sustained organic growth.
Read Full Story
